Cellebrite Di Stock Buy Hold or Sell Recommendation
| CLBT Stock | USD 19.72 0.46 2.28% |
Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding Cellebrite DI is 'Buy'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Cellebrite DI given historical horizon and risk tolerance towards Cellebrite. When Macroaxis issues a 'buy' or 'sell' recommendation for Cellebrite DI, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Cellebrite Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Cellebrite and provide practical buy, sell, or hold advice based on investors' constraints. Cellebrite DI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Cellebrite |
Execute Cellebrite Buy or Sell Advice
The Cellebrite recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cellebrite DI. Macroaxis does not own or have any residual interests in Cellebrite DI or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cellebrite's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Buy
Market Performance | OK | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Cellebrite Trading Alerts and Improvement Suggestions
| The company reported the previous year's revenue of 325.11 M. Net Loss for the year was (81.1 M) with profit before overhead, payroll, taxes, and interest of 219.91 M. | |
| About 47.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Cellebrite DI Ltd. Partners with Relativity to Streamline Mobile Data Collection for Legal Processes, Reducing Time from Days to Hours |
Cellebrite Returns Distribution Density
The distribution of Cellebrite's historical returns is an attempt to chart the uncertainty of Cellebrite's future price movements. The chart of the probability distribution of Cellebrite daily returns describes the distribution of returns around its average expected value. We use Cellebrite DI price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cellebrite returns is essential to provide solid investment advice for Cellebrite.
| Mean Return | 0.27 | Value At Risk | -2.28 | Potential Upside | 3.76 | Standard Deviation | 2.09 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cellebrite historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Cellebrite Stock Institutional Investors
The Cellebrite's institutional investors refer to entities that pool money to purchase Cellebrite's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Pembroke Management Ltd | 2024-09-30 | 1.9 M | Ashford Capital Management Inc | 2024-06-30 | 1.9 M | Blackrock Inc | 2024-06-30 | 1.9 M | Crescent Park Management, L.p. | 2024-09-30 | 1.7 M | Two Sigma Investments Llc | 2024-09-30 | 1.6 M | Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Ltd | 2024-09-30 | 1.5 M | Renaissance Technologies Corp | 2024-09-30 | 1.5 M | Principal Financial Group Inc | 2024-09-30 | 1.4 M | Goldman Sachs Group Inc | 2024-06-30 | 1.3 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 14 M | True Wind Capital Management, L.p. | 2024-09-30 | 11.7 M |
Cellebrite Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cellebrite or Software sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cellebrite's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cellebrite stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.19 | |
β | Beta against Dow Jones | 0.61 | |
σ | Overall volatility | 2.03 | |
Ir | Information ratio | 0.07 |
Cellebrite Volatility Alert
Cellebrite DI has relatively low volatility with skewness of 0.98 and kurtosis of 1.77. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cellebrite's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cellebrite's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Cellebrite Fundamentals Vs Peers
Comparing Cellebrite's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cellebrite's direct or indirect competition across all of the common fundamentals between Cellebrite and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cellebrite or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Cellebrite's fundamental indicators could also be used in its relative valuation, which is a method of valuing Cellebrite by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Cellebrite to competition |
| Fundamentals | Cellebrite | Peer Average |
| Return On Equity | -1.88 | -0.31 |
| Return On Asset | 0.0635 | -0.14 |
| Profit Margin | (0.82) % | (1.27) % |
| Operating Margin | 0.18 % | (5.51) % |
| Current Valuation | 3.88 B | 16.62 B |
| Shares Outstanding | 214.84 M | 571.82 M |
| Shares Owned By Insiders | 46.79 % | 10.09 % |
| Shares Owned By Institutions | 52.99 % | 39.21 % |
| Number Of Shares Shorted | 1.51 M | 4.71 M |
| Price To Earning | 82.18 X | 28.72 X |
| Price To Book | 14.20 X | 9.51 X |
| Price To Sales | 11.00 X | 11.42 X |
| Revenue | 325.11 M | 9.43 B |
| Gross Profit | 219.91 M | 27.38 B |
| EBITDA | (64.8 M) | 3.9 B |
| Net Income | (81.1 M) | 570.98 M |
| Cash And Equivalents | 142.51 M | 2.7 B |
| Cash Per Share | 0.75 X | 5.01 X |
| Total Debt | 14.13 M | 5.32 B |
| Current Ratio | 1.35 X | 2.16 X |
| Book Value Per Share | 1.43 X | 1.93 K |
| Cash Flow From Operations | 102.06 M | 971.22 M |
| Short Ratio | 1.32 X | 4.00 X |
| Earnings Per Share | (1.58) X | 3.12 X |
| Price To Earnings To Growth | 13.39 X | 4.89 X |
| Target Price | 22.43 | |
| Number Of Employees | 1.01 K | 18.84 K |
| Beta | 1.5 | -0.15 |
| Market Capitalization | 4.24 B | 19.03 B |
| Total Asset | 540.4 M | 29.47 B |
| Retained Earnings | 118.14 M | 9.33 B |
| Working Capital | 168.26 M | 1.48 B |
| Net Asset | 540.4 M |
Cellebrite Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cellebrite . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Cellebrite Buy or Sell Advice
When is the right time to buy or sell Cellebrite DI? Buying financial instruments such as Cellebrite Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cellebrite in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Drugs Thematic Idea Now
Drugs
Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. The Drugs theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Drugs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Cellebrite Stock Analysis
When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.